Teleflex (NYSE:TFX) will be issuing its quarterly earnings data before the market opens on Thursday, February 22nd. Analysts expect the company to announce earnings of $2.41 per share for the quarter.
Shares of Teleflex (NYSE TFX) opened at $267.89 on Tuesday. Teleflex has a one year low of $176.79 and a one year high of $288.78. The company has a current ratio of 4.72, a quick ratio of 3.70 and a debt-to-equity ratio of 0.88. The firm has a market cap of $12,070.00, a PE ratio of 48.36, a P/E/G ratio of 1.98 and a beta of 1.15.
TFX has been the topic of a number of recent analyst reports. Morgan Stanley lifted their price objective on shares of Teleflex from $274.00 to $290.00 and gave the company an “equal weight” rating in a research note on Friday, November 3rd. Jefferies Group boosted their price target on shares of Teleflex from $270.00 to $295.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. Leerink Swann reiterated a “buy” rating and issued a $321.00 price target (up from $307.00) on shares of Teleflex in a research report on Tuesday, January 30th. Deutsche Bank cut shares of Teleflex from a “buy” rating to a “hold” rating and set a $251.00 price target on the stock. in a research report on Tuesday, November 14th. Finally, Stephens reiterated a “buy” rating and issued a $300.00 price target on shares of Teleflex in a research report on Thursday, January 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $283.89.
In related news, Director George Babich, Jr. sold 2,500 shares of Teleflex stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $263.38, for a total value of $658,450.00. Following the transaction, the director now owns 10,583 shares of the company’s stock, valued at approximately $2,787,350.54. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Stephen K. M.D. Klasko sold 200 shares of Teleflex stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $265.32, for a total value of $53,064.00. Following the completion of the transaction, the director now directly owns 8,080 shares in the company, valued at approximately $2,143,785.60. The disclosure for this sale can be found here. Insiders sold a total of 10,100 shares of company stock worth $2,671,994 in the last three months. 2.39% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION WARNING: This news story was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/20/teleflex-tfx-scheduled-to-post-earnings-on-thursday.html.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.